• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体阳性浸润性乳腺癌的动态对比增强和扩散加权磁共振成像:磁共振定量参数与Ki-67增殖状态之间的关联。

Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.

作者信息

Shin Jong Ki, Kim Jin You

机构信息

Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea.

Department of Radiology, Pusan National University Hospital, Busan, Republic of Korea.

出版信息

J Magn Reson Imaging. 2017 Jan;45(1):94-102. doi: 10.1002/jmri.25348. Epub 2016 Jun 17.

DOI:10.1002/jmri.25348
PMID:27313102
Abstract

PURPOSE

To explore the association between quantitative parameters derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI) and Ki-67 proliferation status in patients with estrogen receptor (ER)-positive invasive breast cancer.

MATERIALS AND METHODS

We retrospectively reviewed the records of 88 patients with ER-positive invasive breast cancer who underwent preoperative DCE-MRI and DWI on a 3T scanner. Perfusion parameters (K , K , and V ) and apparent diffusion coefficients (ADCs) were recorded, and we correlated these data with the Ki-67 status. The Ki-67 proliferation index was categorized as high (≥14%) or low (<14%).

RESULTS

In the high-Ki-67 group, the mean K was significantly higher (P < 0.001) than that of the low-Ki-67 group, and the mean ADC significantly lower (P < 0.001). However, the mean K and V values did not differ between the two groups (P = 0.248 and P = 0.055, respectively). Univariate analysis showed that a higher K (>0.274), a lower ADC (≤0.893 × 10 mm /s), a larger tumor size (>2 cm), a higher histological grade (grade 3), the presence of axillary metastasis, and positive P53 status were significantly associated with high-Ki-67 status (all P values < 0.05). Of these variables, a higher K (>0.274; adjusted odds ratio [OR] = 9.027, 95% confidence interval [CI] = 1.929-42.245; P = 0.005) and a higher histological grade (grade 3; adjusted OR = 7.510, 95% CI = 1.305-43.205; P = 0.024) independently predicted a high Ki-67 status.

CONCLUSION

K derived from DCE-MRI is associated independently with the Ki-67 proliferation status in patients with ER-positive invasive breast cancer.

LEVEL OF EVIDENCE

4 J. Magn. Reson. Imaging 2017;45:94-102.

摘要

目的

探讨动态对比增强磁共振成像(DCE-MRI)和扩散加权成像(DWI)得出的定量参数与雌激素受体(ER)阳性浸润性乳腺癌患者Ki-67增殖状态之间的关联。

材料与方法

我们回顾性分析了88例ER阳性浸润性乳腺癌患者的记录,这些患者在3T扫描仪上接受了术前DCE-MRI和DWI检查。记录灌注参数(Ktrans、Kep和Ve)和表观扩散系数(ADC),并将这些数据与Ki-67状态进行关联。Ki-67增殖指数分为高(≥14%)或低(<14%)。

结果

在高Ki-67组中,平均Ktrans显著高于低Ki-67组(P<0.001),平均ADC显著低于低Ki-67组(P<0.001)。然而,两组之间的平均Kep和Ve值没有差异(分别为P=0.248和P=0.055)。单因素分析显示,较高的Ktrans(>0.274)、较低的ADC(≤0.893×10⁻³mm²/s)、较大的肿瘤大小(>2cm)、较高的组织学分级(3级)、腋窝转移的存在以及P53状态阳性与高Ki-67状态显著相关(所有P值<0.05)。在这些变量中,较高的Ktrans(>0.274;调整后的优势比[OR]=9.027,95%置信区间[CI]=1.929-42.245;P=0.005)和较高的组织学分级(3级;调整后的OR=7.510,95%CI=1.305-43.205;P=0.024)独立预测高Ki-67状态。

结论

DCE-MRI得出的Ktrans与ER阳性浸润性乳腺癌患者的Ki-67增殖状态独立相关。

证据水平

4 J.Magn.Reson.Imaging 2017;45:94-102。

相似文献

1
Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.雌激素受体阳性浸润性乳腺癌的动态对比增强和扩散加权磁共振成像:磁共振定量参数与Ki-67增殖状态之间的关联。
J Magn Reson Imaging. 2017 Jan;45(1):94-102. doi: 10.1002/jmri.25348. Epub 2016 Jun 17.
2
Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.肿瘤表观扩散系数作为一种成像生物标志物,用于预测雌激素受体阳性乳腺癌患者的肿瘤侵袭性。
NMR Biomed. 2016 Aug;29(8):1070-8. doi: 10.1002/nbm.3571. Epub 2016 Jun 22.
3
Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.应用扩散峰度成像和定量动态对比增强磁共振成像鉴别乳腺肿瘤。
J Magn Reson Imaging. 2018 Nov;48(5):1358-1366. doi: 10.1002/jmri.26059. Epub 2018 May 2.
4
Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.弥散加权成像(DWI)及其表观扩散系数(ADC)图作为一种定量影像学生物标志物,可预测乳腺癌的免疫组织化学受体状态、增殖率和分子亚型。
J Magn Reson Imaging. 2019 Sep;50(3):836-846. doi: 10.1002/jmri.26697. Epub 2019 Feb 27.
5
Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.DCE-MRI 定量药代动力学参数的直方图分析:与乳腺癌预后因素和分子亚型的相关性。
Breast Cancer. 2019 Jan;26(1):113-124. doi: 10.1007/s12282-018-0899-8. Epub 2018 Aug 1.
6
Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.动态对比增强和弥散加权磁共振成像的三阴性浸润性乳腺癌:与其他乳腺癌亚型的比较。
Eur Radiol. 2012 Aug;22(8):1724-34. doi: 10.1007/s00330-012-2425-2. Epub 2012 Apr 17.
7
Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.扩散峰度成像与动态对比增强 MRI 对乳腺癌患者预后因素和分子亚型预测的比较。
Eur J Radiol. 2022 Sep;154:110392. doi: 10.1016/j.ejrad.2022.110392. Epub 2022 Jun 3.
8
Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status.宫颈癌的动态对比增强和弥散加权 MRI:与 Ki-67 增殖状态的相关性。
Magn Reson Imaging. 2024 Oct;112:136-143. doi: 10.1016/j.mri.2024.07.010. Epub 2024 Jul 17.
9
Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.评估动态对比增强磁共振成像(DCE-MRI)参数与乳腺癌病理特征之间的关系。
J Magn Reson Imaging. 2020 Nov;52(5):1360-1373. doi: 10.1002/jmri.27241. Epub 2020 Jun 10.
10
Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.利用体素内不相干运动和动态对比增强磁共振成像鉴别腔面A型和腔面B型乳腺癌
Acad Radiol. 2017 Dec;24(12):1575-1581. doi: 10.1016/j.acra.2017.06.016. Epub 2017 Aug 1.

引用本文的文献

1
Distributed parameter model of dynamic contrast-enhanced MRI in the identification of IDH mutation, 1p19q codeletion, and tumor cell proliferation in glioma patients.动态对比增强磁共振成像的分布参数模型在胶质瘤患者异柠檬酸脱氢酶(IDH)突变、1p19q共缺失及肿瘤细胞增殖识别中的应用
Front Oncol. 2024 Oct 25;14:1333798. doi: 10.3389/fonc.2024.1333798. eCollection 2024.
2
Non-contrast Breast MR Imaging.乳腺非增强磁共振成像
Radiol Clin North Am. 2024 Jul;62(4):661-678. doi: 10.1016/j.rcl.2023.12.009. Epub 2024 Mar 7.
3
Correlation of Perfusion Metrics with Ki-67 Proliferation Index and Axillary Involvement as a Prognostic Marker in Breast Carcinoma Cases: A Dynamic Contrast-Enhanced Perfusion MRI Study.
乳腺癌病例中灌注指标与Ki-67增殖指数及腋窝受累情况的相关性作为预后标志物:一项动态对比增强灌注磁共振成像研究
Diagnostics (Basel). 2023 Oct 19;13(20):3260. doi: 10.3390/diagnostics13203260.
4
Radiomics and artificial intelligence analysis by T2-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging to predict Breast Cancer Histological Outcome.基于 T2 加权成像和动态对比增强磁共振成像的放射组学和人工智能分析预测乳腺癌组织学结局。
Radiol Med. 2023 Nov;128(11):1347-1371. doi: 10.1007/s11547-023-01718-2. Epub 2023 Oct 6.
5
High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.高时间分辨率 DCE-MRI 提高了 BI-RADS 4 类乳腺内及周围病变的评估能力。
BMC Med Imaging. 2023 Apr 19;23(1):58. doi: 10.1186/s12880-023-01015-4.
6
Use of biexponential and stretched exponential models of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging to assess the proliferation of endometrial carcinoma.使用体素内不相干运动的双指数和拉伸指数模型以及动态对比增强磁共振成像评估子宫内膜癌的增殖情况。
Quant Imaging Med Surg. 2023 Apr 1;13(4):2568-2581. doi: 10.21037/qims-22-688. Epub 2023 Feb 16.
7
Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.动态对比增强磁共振成像参数图和表观扩散系数图的影像组学预测乳腺癌Ki-67状态
Front Oncol. 2022 Nov 25;12:847880. doi: 10.3389/fonc.2022.847880. eCollection 2022.
8
Radiomics signatures based on contrast-enhanced CT for preoperative prediction of the Ki-67 proliferation state in gastrointestinal stromal tumors.基于增强 CT 的影像组学特征术前预测胃肠道间质瘤 Ki-67 增殖状态
Jpn J Radiol. 2023 Jul;41(7):741-751. doi: 10.1007/s11604-023-01391-5. Epub 2023 Jan 18.
9
Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.乳腺癌亚型与定量磁共振成像:一项系统综述
Life (Basel). 2022 Mar 28;12(4):490. doi: 10.3390/life12040490.
10
Prediction of Prognostic Factors and Genotypes in Patients With Breast Cancer Using Multiple Mathematical Models of MR Diffusion Imaging.使用磁共振扩散成像的多种数学模型预测乳腺癌患者的预后因素和基因型
Front Oncol. 2022 Jan 31;12:825264. doi: 10.3389/fonc.2022.825264. eCollection 2022.